Study title: A Phase III, Prospective, Placebo-Controlled, Double-Blinded, Randomized, Multi-Center Study to Determine the Safety and Efficacy of Calcijex® (Calcitriol Injection) in Decreasing Serum Intact Parathyroid Hormone Levels in Pediatric End Stage Renal Disease Patients on Hemodialysis
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: CALCITRIOL | |||||
ATC code: | |||||
Document link: Calcitriol-1999007.pdf | |||||
Document date: 2011-09-13 | |||||
Study number: 1999007 | |||||
EudraCT number: | |||||
Scope of study: | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |